A postponed MAHA report's leaked draft strategy calls for heightened scrutiny of pharmaceutical direct-to-consumer (DTC) advertising, especially on social media where telehealth companies use deceptive marketing tactics. The draft recommends increased oversight by FDA, HHS, FTC and DOJ and signals potential policy reforms short of an outright ban. Robert F. Kennedy Jr. has long targeted DTC ads, and past calls for bans contrast with the draft's softer approach. The administration delayed the report to coordinate officials' schedules. The first MAHA report earlier identified problems in food and health systems and faced criticism for factual errors and alleged AI use.
In the upcoming report, health leaders may seek to crack down on DTC ads, particularly on social media where telehealth companies use "deceptive" marketing tactics, according to draft strategy documents published by Politico. The leaked draft strategy contains policy recommendations from a group assembled by President Donald Trump and Kennedy, and its objectives could change before the official version is published. The White House stated it delayed the report's release to coordinate the schedules of officials involved in creating it, Politico reported.
Based on the draft strategy for the second report, pharma should brace for heightened scrutiny of DTC advertisements. DTC oversight In the past, Kennedy has suggested that pharma DTC advertising should be outlawed completely, but the drafted strategy appears to take a softer approach. Rather than seeking an outright ban, the recommendations are significantly less damaging to pharma's status quo.
Collection
[
|
...
]